DMAA — Drugs Made In America Acquisition Corp. Ordinary Shares stock price, charts and financials

QT45Drugs Made In America Acquisition Corp. Ordinary Shares

NASDAQ·Financial Services·Shell Companies·USA

Latest market price

10.71

+0.00%

Overview Short InterestFilings

DMAAQT45Drugs Made In America Acquisition Corp. Ordinary Shares·NASDAQ

Overview Short InterestFilings

10.71+0.00%

Loading chart...

Screen all →

TACH+0.00%$10.44 ALUB+0.00%$10.10 OTGA+0.10%$10.18 CCII-0.10%$10.33 ARCI+0.00%$10.14 ACAA+0.00%$10.00 KCHV+0.10%$10.40 FCRS-0.10%$10.23

Snapshot

Index	-	P/E	52.35	EPS (ttm)	0.20	Insider Own	-	Shs Outstand	33.72M	Perf Week	0.09%

Market Cap	361.11M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	27.31M	Perf Month	0.66%

Enterprise Value	361.20M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	0.34%	Perf Quarter	1.71%

Income	9.75M	P/S	0.00	EPS this Y	-	Inst Trans	-	Short Ratio	0.86	Perf Half Y	2.59%

Sales	0.00	P/B	1.05	EPS next Y	-	ROA	2.75%	Short Interest	93.89K	Perf YTD	3.28%

Book/sh	-	P/C	-	EPS next 5Y	-	ROE	2.88%	52W High	10.72 -0.09%	Perf Year	4.28%

Cash/sh	-	P/FCF	-	EPS past 3/5Y	-	ROIC	-1.09%	52W Low	10.22 4.79%	Perf 3Y	-

Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-	Gross Margin	0.00%	Volatility	0.06% 0.15%	Perf 5Y	-

Dividend TTM	-	EV/Sales	0.00	EPS Y/Y TTM	-	Oper. Margin	0.00%	ATR (14)	0.02	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	0.03	Sales Y/Y TTM	-	Profit Margin	0.00%	RSI (14)	68.72	Recom	-

Dividend Gr. 3/5Y	-	Current Ratio	0.03	EPS Q/Q	-	SMA20	0.24%	Beta	-0.00	Target Price	-

Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	-	SMA50	0.61%	Rel Volume	0.24	Prev Close	10.71

Employees	2	LT Debt/Eq	-	Earnings	-	SMA200	2.17%	Avg Volume	35.96K	Price	10.71

IPO Date	Jan 27, 2025	Option/Short	Yes / Yes	EPS/Sales Surpr.	-	Net Debt/EBITDA	-0.03	Volume	8,532	Change	0.00%

Company

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	FY 2025 12/31/2025	FY 2024 12/31/2024
Total Revenue	0	0
Cost of Goods Sold Incl. D&A	0	0
Gross Profit	0	0
Selling, General and Administrative Excl. Other	3	0
Research and Development	0	0
Other Operating Expense	0	0
Operating Income	-3	0
Interest Expense	0	0
Unusual Expense	—	—
Non-Operating Income (Expense)	9	0
Net Income Before Taxes	6	0
Income Taxes	0	0
Consolidated Net Income	6	0
Net Income From Continuing Operations	6	0
Net Income	6	0
EPS (Recurring)	0.19	-0.06
EPS (Basic, Before Extraordinaries)	0.19	-0.06
EPS (Diluted)	0.19	-0.06
EBITDA	-3	0
Other After Tax Adjustments	—	—
Stock Option Compensation Expense	—	—
Price To Earnings Ratio	54.58	—
Price To Sales Ratio	—	—
Gross Margin	—	—
Operating Margin	—	—
Net Margin	—	—
Shares Outstanding	21	9
Market Capitalization	218	—
Operating Lease Expense	—	—

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Drugs Made In America Acquisition LLC	10% Owner	Feb 18 '25	Buy	0.00	60,000	0	4,188,780	Feb 18
Stockwell Lynn	CEO and Exe. Chair of Board	Feb 18 '25	Buy	0.00	60,000	0	4,188,780	Feb 18
Drugs Made In America Acquisition LLC	10% Owner	Jan 29 '25	Buy	0.00	800,000	0	10,257,143	Feb 04
Drugs Made In America Acquisition LLC	10% Owner	Jan 29 '25	Sale	1.50	5,698,363	8,547,545	4,158,780	Feb 04
Stockwell Lynn	CEO and Executive COB	Jan 29 '25	Sale	1.50	5,698,363	8,547,545	4,158,780	Feb 04
Stockwell Lynn	CEO and Executive COB	Jan 29 '25	Buy	0.00	800,000	0	400,000	Feb 04

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.